David H. Crean, PhD, MBA
David H. Crean, PhD, MBA is Chief Business Officer of MediciNova, Inc. (NASDAQ: MNOV; TSE: 4875) and Founder and Managing Partner of Cardiff Advisory LLC, a life sciences mergers and acquisitions and strategic advisory firm based in San Diego. He has more than three decades of experience in biopharmaceutical business development, investment banking, and venture investing, and has closed transactions across biopharma, medtech, and diagnostics. He holds FINRA Series 79 and Series 63 registrations. He holds a PhD in Biophysics from the State University of New York at Buffalo and an MBA in Finance from Pepperdine University.
